Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.34 |
| ▸ | RXRB | P28702 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 2/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19196617 | 1.00 | KDM4E (0.42) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL15338025 | 0.98 | L3MBTL1 (0.44) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL16675625 | 0.95 | KDM4E (0.40) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL16641313 | 0.95 | KDM4E (0.42) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL14822513 | 0.95 | KDM4E (0.42) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL16675630 | 0.95 | KDM4E (0.42) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL15583006 | 0.95 | KDM4E (0.42) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL19653455 | 0.94 | L3MBTL1 (0.41) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL19653531 | 0.94 | L3MBTL1 (0.41) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL23370542 | 0.94 | KDM4E (0.43) | KDM4EATML3MBTL1RXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170222160-A1 | ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME | SFC CO., LTD. (KR) | 2017-08-03 | — | — | US | disclosed |
| US-20170222160-A1 | ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME | SFC CO., LTD. (KR) | 2017-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170222160-A1 | ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME | ALDH1A2, LAGE3, AOX1 | KDM4E 1340/4885ATM 4310/4885L3MBTL1 75/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.